SFO - Science Foundation for Oncology
Company Overview
Previous Company Names
- Stiftung für die Forschung in der Onkologie
Management
Holger Moch
Zürich
Member of the foundation board
Joint signing authority (any two to sign)
Markus Manz
Zürich
Chairperson of the foundation board
Joint signing authority (any two to sign)
Alexander Knuth
Zürich
Member of the foundation board
Joint signing authority (any two to sign)
Dirk Jäger
Zürich
Member of the foundation board
Individual signing authority
Elke Jäger
Mainz-Kostheim
Member of the foundation board
Individual signing authority
Marco Lorez
Meilen
Member of the foundation board + secretary
Joint signing authority (any two to sign)
Wilhelm Vetter
Dübendorf
Member of the foundation board
Joint signing authority (any two to sign)
Christoph Renner
Zürich
Member of the foundation board
Joint signing authority (any two to sign)
Wilhelm Vetter
Zürich
Member of the foundation board
Joint signing authority (any two to sign)
Gregor Zünd
Herrliberg
Member of the foundation board
Joint signing authority (any two to sign)
Jill O'Donnell-Tormey
New York
Member of the foundation board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 31565 | 27.07.2023 | 147 | 02.08.2023 | 1005808083 |
| 2 | 37727 | 02.10.2020 | 195 | 07.10.2020 | 1004994264 |
| 3 | 6286 | 08.02.2019 | 30 | 13.02.2019 | 1004565111 |
| 4 | 29823 | 10.09.2014 | 177 | 15.09.2014 | 1714041 |
| 5 | 25918 | 27.07.2012 | 148 | 02.08.2012 | 6794594 |
| 6 | 6747 | 20.02.2012 | 38 | 23.02.2012 | 6565380 |
| 7 | 39491 | 02.11.2011 | 216 | 07.11.2011 | 6405692 |
| 8 | 38000 | 27.10.2010 | 213 | 02.11.2010 | 25/5877886 |
| 9 | 32375 | 20.08.2009 | 164 | 26.08.2009 | 28/5216254 |
| 10 | 17005 | 18.06.2008 | 120 | 24.06.2008 | 29/4539288 |
Company Purpose
Die Stiftung hat den Zweck, unter Einsatz sachlicher, finanzieller und personeller Mittel die universitäre Forschung in der Onkologie am Standort Zürich zu fördern. Insbesondere soll der wissenschaftliche Austausch auf dem Gebiet der Onkologie und Tumorimmunologie gefördert werden.